SCHEMBL13619929

SCHEMBL13619929

[O-]/[N+](=N\O)N(c1ccccc1)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
TDP1 Q9NUW8 2/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NR1H3 Q13133 4/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CRHBP P24387 1/20 0.33
ATM Q13315 1/20 0.33
CRHR2 Q13324 1/20 0.33
TLR9 Q9NR96 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MLYCD O95822 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
ALOX15 P16050 1/20 0.31
NR1H2 P55055 2/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13619931 0.78 ALDH1A1 (0.44) ALDH1A1TDP1CYP3A4HSD17B10MEN1
SCHEMBL2784009 0.78 ALDH1A1 (0.42) ALDH1A1TDP1HPGDNR1H3MEN1
SCHEMBL13619903 0.74 ALDH1A1 (0.43) ALDH1A1TDP1CYP3A4HPGDHSD17B10
SCHEMBL16727258 0.71 MEN1 (0.41) ALDH1A1TDP1CYP3A4HPGDHSD17B10
Nitric Acid SCHEMBL28373917 0.65 MEN1 (0.40) ALDH1A1HPGDNR1H3MEN1KMT2A
SCHEMBL15400452 0.64 NPSR1 (0.39) ALDH1A1CYP3A4HPGDNR1H3MEN1
SCHEMBL30947663 0.63 ALDH1A1 (0.41) ALDH1A1TDP1CYP3A4HPGDHSD17B10
SCHEMBL728216 0.63 ALDH1A1 (0.41) ALDH1A1TDP1CYP3A4HPGDNR1H3
SCHEMBL6911977 0.63 ALDH1A1 (0.41) ALDH1A1TDP1CYP3A4HPGDHSD17B10
SCHEMBL13619902 0.62 ALDH1A1 (0.43) ALDH1A1TDP1CYP3A4HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10273202-B2 Nitroxyl progenitor compounds and methods of use THE JOHNS HOPKINS UNIVERSITY (US) 2019-04-30 US disclosed
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use THE JOHN HOPKINS UNIVERSITY (US) 2009-11-12 US disclosed
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use THE JOHN HOPKINS UNIVERSITY (US) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281067-A1 Nitroxyl progenitor compounds and methods of use HMOX2, NNMT, HMOX1 ALDH1A1 37/4885TDP1 897/4885CYP3A4 1820/4885
US-10273202-B2 Nitroxyl progenitor compounds and methods of use HMOX2, NNMT, HMOX1 ALDH1A1 37/4885TDP1 897/4885CYP3A4 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.